| Literature DB >> 17306910 |
Yves Jackson1, François Chappuis, Nathalie Mezger, Kathi Kanappa, Louis Loutan.
Abstract
Travellers often present late for the third dose of hepatitis B vaccination and measuring anti-HBs serology is common practice to ensure that these individuals are protected. We assessed the adequacy of immune response in 86 healthy travellers who had their third dose of hepatitis B (HB) vaccine performed more than 1 year (median: 3.4 years; range: 1.1-10.5 years) after the second dose. Eighty-two travellers (95.3%) had evidence of sero-protection (anti-HBs titre >10 UI/L) including 16/17 (94.1%) travellers who had an interval of more than 5 years between second and third vaccine dose. We did not find any risk factor associated with insufficient response.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17306910 DOI： 10.1016/j.vaccine.2006.12.053
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641